Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 38 Records) |
| Query Trace: Liver Diseases and IL28B[original query] |
|---|
| Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. Hepatology (Baltimore, Md.) 2012 Jan 55 (1): 20-9. Asahina Yasuhiro, Tsuchiya Kaoru, Muraoka Masaru, Tanaka Keisuke, Suzuki Yuichiro, Tamaki Nobuharu, Hoshioka Yoshihide, Yasui Yutaka, Katoh Tomoji, Hosokawa Takanori, Ueda Ken, Nakanishi Hiroyuki, Itakura Jun, Takahashi Yuka, Kurosaki Masayuki, Enomoto Nobuyuki, Nitta Sayuri, Sakamoto Naoya, Izumi Nami |
| Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4. Hepatology (Baltimore, Md.) 2012 Feb 55 (2): 336-42. De Nicola Stella, Aghemo Alessio, Rumi Maria Grazia, Galmozzi Enrico, Valenti Luca, Soffredini Roberta, De Francesco Raffaele, Prati Gian Maria, D'Ambrosio Roberta, Cheroni Cristina, Donato Maria Francesca, Colombo Massi |
| Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias? Hepatology (Baltimore, Md.) 2012 Jan 55 (1): 30-8. Beinhardt Sandra, Staettermayer Albert F, Rutter Karoline, Maresch Judith, Scherzer Thomas M, Steindl-Munda Petra, Hofer Harald, Ferenci Pet |
| Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection. Hepatology (Baltimore, Md.) 2011 Oct 54 (4): 1127-34. Marabita Francesco, Aghemo Alessio, De Nicola Stella, Rumi Maria G, Cheroni Cristina, Scavelli Rossana, Crimi Marco, Soffredini Roberta, Abrignani Sergio, De Francesco Raffaele, Colombo Massi |
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes. Hepatology (Baltimore, Md.) 2012 Feb 55 (2): 384-94. Bochud Pierre-Yves, Bibert Stéphanie, Kutalik Zoltán, Patin Etienne, Guergnon Julien, Nalpas Bertrand, Goossens Nicolas, Kuske Lorenz, Müllhaupt Beat, Gerlach Tillman, Heim Markus H, Moradpour Darius, Cerny Andreas, Malinverni Raffaele, Regenass Stephan, Dollenmaier Guenter, Hirsch Hans, Martinetti Gladys, Gorgiewski Meri, Bourlière Marc, Poynard Thierry, Theodorou Ioannis, Abel Laurent, Pol Stanislas, Dufour Jean-François, Negro Francesco, , |
Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.
Hepatology (Baltimore, Md.) 2012 Apr 55 (4): 1038-47. Lange Christian M, Kutalik Zoltan, Morikawa Kenichi, Bibert Stéphanie, Cerny Andreas, Dollenmaier Günter, Dufour Jean-François, Gerlach Tilman J, Heim Markus H, Malinverni Raffaele, Müllhaupt Beat, Negro Francesco, Moradpour Darius, Bochud Pierre-Yves, |
| Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin. Hepatology (Baltimore, Md.) 2011 Nov 54 (5): 1518-26. Scherzer Thomas-Matthias, Stättermayer Albert Friedrich, Strasser Michael, Laferl Hermann, Maieron Andreas, Stauber Rudolf, Datz Christian, Dulic-Lakovic Emina, Steindl-Munda Petra, Hofer Harald, Ferenci Pet |
| Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis. Hepatology (Baltimore, Md.) 2012 Dec 56 (6): 2134-41. Akuta Norio, Suzuki Fumitaka, Seko Yuya, Kawamura Yusuke, Sezaki Hitomi, Suzuki Yoshiyuki, Hosaka Tetsuya, Kobayashi Masahiro, Hara Tasuku, Kobayashi Mariko, Saitoh Satoshi, Arase Yasuji, Ikeda Kenji, Kumada Hiromit |
| Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response. Hepatitis monthly 2012 Mar 12 (3): 190-5. Sharafi Heidar, Pouryasin Ali, Alavian Seyed Moayed, Behnava Bita, Keshvari Maryam, Mehrnoush Leila, Salimi Shima, Kheradvar Osv |
| IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology (Baltimore, Md.) 2013 Mar 57 (3): 890-6. Lampertico Pietro, Viganò Mauro, Cheroni Cristina, Facchetti Floriana, Invernizzi Federica, Valveri Vincenza, Soffredini Roberta, Abrignani Sergio, De Francesco Raffaele, Colombo Massi |
| HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology (Baltimore, Md.) 2012 Jul 56 (1): 86-94. Uccellini Lorenzo, Tseng Fan-Chen, Monaco Alessandro, Shebl Fatma M, Pfeiffer Ruth, Dotrang Myhanh, Buckett Dianna, Busch Michael P, Wang Ena, Edlin Brian R, Marincola Francesco M, O'Brien Thomas |
| Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response. Hepatology (Baltimore, Md.) 2012 Aug 56 (2): 444-54. Naggie Susanna, Osinusi Anu, Katsounas Antonios, Lempicki Richard, Herrmann Eva, Thompson Alexander J, Clark Paul J, Patel Keyur, Muir Andrew J, McHutchison John G, Schlaak Joerg F, Trippler Martin, Shivakumar Bhavana, Masur Henry, Polis Michael A, Kottilil Shy |
| Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology (Baltimore, Md.) 2012 Jun 55 (6): 1700-10. Fischer Janett, Böhm Stephan, Scholz Markus, Müller Tobias, Witt Heiko, George Jacob, Sarrazin Christoph, Susser Simone, Schott Eckart, Suppiah Vijayaprakash, Booth David R, Stewart Graeme J, van Bömmel Florian, Brodzinski Annika, Fülöp Balazs, Migaud Pascal, Berg Thom |
| The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (Baltimore, Md.) 2014 Jan 59 (1): 109-20. Grebely Jason, Page Kimberly, Sacks-Davis Rachel, van der Loeff Maarten Schim, Rice Thomas M, Bruneau Julie, Morris Meghan D, Hajarizadeh Behzad, Amin Janaki, Cox Andrea L, Kim Arthur Y, McGovern Barbara H, Schinkel Janke, George Jacob, Shoukry Naglaa H, Lauer Georg M, Maher Lisa, Lloyd Andrew R, Hellard Margaret, Dore Gregory J, Prins Maria, |
| Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C. Journal of gastroenterology and hepatology 2014 Feb 29 (2): 337-43. Matsushita Hiroshi, Ikeda Fusao, Iwasaki Yoshiaki, Seki Hiroyuki, Nanba Shintaro, Takeuchi Yasuto, Moritou Yuki, Yasunaka Tetsuya, Onishi Hideki, Miyake Yasuhiro, Takaki Akinobu, Nouso Kazuhiro, Yamamoto Kazuhi |
| Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis. Hepatology (Baltimore, Md.) 2013 May . Noureddin M, Wright EC, Alter H, Clark S, Thomas E, Chen R, Zhao X, Conry-Cantilena C, Kleiner D, Liang TJ, Ghany MG |
| Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes. Hepatology (Baltimore, Md.) 2013 Oct . Honda M, Shirasaki T, Shimakami T, Sakai A, Horii R, Arai K, Yamashita T, Sakai Y, Yamashita T, Okada H, Murai K, Nakamura M, Mizukoshi E, Kaneko S |
| PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients. Hepatology (Baltimore, Md.) 2013 Jan . Wedemeyer H, Jensen D, Herring R, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Lou Munson M, Chen YC, Najera I, Thommes J |
| Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. European journal of gastroenterology & hepatology 2014 Nov 26 (11): 1189-201. Yee Brittany E, Nguyen Nghia H, Zhang Bing, Vutien Philip, Wong Carrie R, Lutchman Glen A, Nguyen Mindie |
| Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology (Baltimore, Md.) 2014 Jun 59 (6): 2083-91. Kumada Hiromitsu, Suzuki Yoshiyuki, Ikeda Kenji, Toyota Joji, Karino Yoshiyasu, Chayama Kazuaki, Kawakami Yoshiiku, Ido Akio, Yamamoto Kazuhide, Takaguchi Koichi, Izumi Namiki, Koike Kazuhiko, Takehara Tetsuo, Kawada Norifumi, Sata Michio, Miyagoshi Hidetaka, Eley Timothy, McPhee Fiona, Damokosh Andrew, Ishikawa Hiroki, Hughes Er |
| Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients. Antiviral therapy 2014 19 (8): 747-53. Degasperi Elisabetta, Valenti Luca, Aghemo Alessio, De Francesco Raffaele, Rumi Mariagrazia, Soffredini Roberta, Donnici Lorena, Cheroni Cristina, Fargion Silvia, Zanoni Valeria, Orsi Emanuela, Colombo Massi |
| Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. Hepatology (Baltimore, Md.) 2014 Jun 59 (6): 2131-9. Rembeck Karolina, Waldenström Jesper, Hellstrand Kristoffer, Nilsson Staffan, Nyström Kristina, Martner Anna, Lindh Magnus, Norkrans Gunnar, Westin Johan, Pedersen Court, Färkkilä Martti, Langeland Nina, Buhl Mads Rauning, Mørch Kristine, Christensen Peer Brehm, Lagging Mart |
| GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis C: A Prospective Cross-Sectional Study. Medicine 2016 Mar 95 (10): e3019. Mateos-Muñoz Beatriz, García-Martín Elena, Torrejón María J, Devesa-Medina María J, Esguevillas Gara, Cárdenas María C, Fernández Cristina, Carballo Miguel, Agúndez José A, Ladero José |
| Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study. Hepatology (Baltimore, Md.) 2016 Jan . Kwo Paul, Gitlin Norman, Nahass Ronald, Bernstein David, Etzkorn Kyle, Rojter Sergio, Schiff Eugene, Davis Mitchell, Ruane Peter, Younes Ziad, Kalmeijer Ronald, Sinha Rekha, Peeters Monika, Lenz Oliver, Fevery Bart, De La Rosa Guy, Scott Jane, Witek Jam |
| Identification of novel variants in HLA class II region related to HLA DPB1 expression and disease progression in patients with chronic hepatitis C. Journal of medical virology 2017 Mar . Hiramatsu Katsushi, Matsuda Hidetaka, Nemoto Tomoyuki, Nosaka Takuto, Saito Yasushi, Naito Tatsushi, Takahashi Kazuto, Ofuji Kazuya, Ohtani Masahiro, Suto Hiroyuki, Yasuda Toshihiro, Hida Yukio, Kimura Hideki, Soya Yoshihiro, Nakamoto Yasuna |
| Genetic Polymorphisms of the IFNLR1 Gene Correlate with HCV Infection and Biochemical Features of Chronic HCV Patients in Yunnan, China. Immunological investigations 2019 8 49 (4): 453-461. Zhang A-Mei, Wang Yiqian, Xia Xueshan, Song Yuz |
| Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma. Frontiers in microbiology 2019 10 475. De Re Valli, Tornesello Maria Lina, De Zorzi Mariangela, Caggiari Laura, Pezzuto Francesca, Leone Patrizia, Racanelli Vito, Lauletta Gianfranco, Gragnani Laura, Buonadonna Angela, Vaccher Emanuela, Zignego Anna Linda, Steffan Agostino, Buonaguro Franco |
| Impact of IL28 Genotypes and Modeling the Interactions of HCV Core Protein on Treatment of Hepatitis C. Interdisciplinary sciences, computational life sciences 2020 7 12 (4): 424-437. Hashempour Tayebeh, Dehghani Behzad, Musavi Zahra, Moayedi Javad, Hasanshahi Zahra, Sarvari Jamal, Hosseini Seyed Younes, Hosseini Ebrahim, Moeini Maryam, Merat Shah |
| PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2020 Oct . Agrawal Tanvi, Gaggar Anuj, Subramanian Mani, Kottilil Shyam, Choudhary Abhijit, Rao Padaki N, Shah Sameer, Trehanpati Nirup |
| Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis. Journal of translational autoimmunity 2021 4 100126. Gatselis Nikolaos K, Azariadis Kalliopi, Lyberopoulou Aggeliki, Dalekos George |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: